Systematic analysis of telomere length and somatic alterations in 31 cancer types

Barthel, Floris P, Wei, Wei, Tang, Ming, Martinez-Ledesma, Emmanuel, Hu, Xin, Amin, Samirkumar B, Akdemir, Kadir C, Seth, Sahil +7 more·2017·Nature Genetics
DOI 10.1038/ng.3781

Cited by (615)

Items 401–500 of 615

  1. Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach
    Ricardo Cortez Cardoso Penha, Alexandra Sexton‐Oates, Sergey Senkin, Hanla A. Park, Joshua Atkins, Ivana Holcátová, Anna Horňáková, Slaviša Savić, Simona Ognjanovic, Beata Świątkowska et al. · 2024 · Molecular Systems Biology
  2. Exploring the role of TERT in thyroid Cancer: A systematic review
    Thais Maloberti, Andrea Repaci, Laura Poppi, Floriana Jessica Di Paola, Giulia Calafato, Sara Coluccelli, Francesca Carosi, Alessandra Colapinto, Simone Colombero, Giacomo Credi et al. · 2025 · Critical Reviews in Oncology/Hematology
  3. Differential immunohistochemical expression of hTERT in lung cancer patients with and without idiopathic pulmonary fibrosis
    Georgia Gomatou, Christos Masaoutis, Ioannis N. Vamvakaris, Elias Alexandros Kotteas, Evangelos Bouros, Vasilios Tzilas, Demosthenes E. Bouros · 2022 · Pulmonology
  4. Evaluation of TERT mRNA expression using RNAscope®: A potential histopathologic diagnostic and prognostic tool
    Amir Momeni Boroujeni, Elham Yousefi, Sounak Gupta, Ryma Benayed, Michael F. Berger, Marc Ladanyi, Robert Monroe, Jeff Kim, Achim A. Jungbluth, Britta Weigelt et al. · 2022 · Pathology - Research and Practice
  5. Major genomic mutations driving hepatocellular carcinoma
    Ran Chen, Mou-Bin Lin, Da-Ming Gao · 2023 · Genome Instability & Disease
  6. pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
    Leyla Blanco-García, Yolanda Ruano, Raquel Blanco Martínez-Illescas, Rocío Cubo Martínez, Paula Jiménez Sánchez, Victor Javier Sanchez-Arevalo Lobo, Erica Riveiro‐Falkenbach, Pablo Luis Ortiz-Romero, María C. Garrido, José Luis Rodríguez‐­Peralto · 2023 · Heliyon
  7. Activating somatic and germline TERT promoter variants in myeloid malignancies
    Valeria Nofrini, Caterina Matteucci, Fabrizia Pellanera, Paolo Gorello, Danika Di Giacomo, Anair Graciela Lema Fernandez, Carlotta Nardelli, Tamara Iannotti, Lucia Brandimarte, Silvia Arniani et al. · 2020 · Leukemia
  8. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma
    Woo Cheal Cho, Wen Li, Jun Gu, Wei‐Lien Wang, Jing Ning, Steven M. Sfamenos, Pavandeep Gill, Priyadharsini Nagarajan, Jonathan L. Curry, Alexander J. Lazar et al. · 2023 · Journal of Cutaneous Pathology
  9. The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas
    Alexandra G. Kouroukli, Anja Fischer, Helene Kretzmer, Emil Chteinberg, Nivethika Rajaram, Selina Glaser, Julia Kolarova, Pavel Bashtrykov, Stephan Mathas, Hans Günter Drexler et al. · 2023 · Blood Cancer Journal
  10. Mechanisms and molecular characterization of relapsed/refractory neuroblastomas
    Chong Chen, Zixuan Wei · 2025 · Frontiers in Oncology
  11. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
    Marta Falcinelli, Giulia Dell’Omo, Elena Grassi, Elisa Mariella, Simonetta Maria Leto, Sharon Scardellato, Annalisa Lorenzato, Sabrina Arena, Andrea Bertotti, Livio Trusolino et al. · 2023 · Cell Death and Disease
  12. CRISPR-based m6A modification and its potential applications in telomerase regulation
    Mingliang Yi, Mingyue Wang, Yongjie Xu, Zhikun Cao, Yinghui Ling, Zijun Zhang, Hongguo Cao · 2023 · Frontiers in Cell and Developmental Biology
  13. Assessment of aggressive bladder cancer mutations in plasma cell-free DNA
    Raquel Carrasco, Mercedes Ingelmo‐Torres, Josep Oriola, Fiorella L. Roldán, Leonardo Rodríguez‐Carunchio, Sandra Herranz, Begoña Mellado, Antonio Alcaraz, Laura Izquierdo, Lourdes Mengual · 2023 · Frontiers in Oncology
  14. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation
    Leon J. Wils, Marijke Buijze, Marijke van Walsum, Arjen Brink, Britt E. van Kempen, Laura A. N. Peferoen, Elisabeth R.E.A. Brouns, Jan G. A. M. de Visscher, E.H. van der Meij, Elisabeth Bloemena et al. · 2024 · Cells
  15. The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres
    Mindy Kim Graham, Beisi Xu, Christine Davis, Alan Keith Meeker, Christopher M. Heaphy, Srinivasan Yegnasubramanian, Michael A. Dyer, Maged Zeineldin · 2024 · Cancer Research Communications
  16. hTERT Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer
    Simeon Santourlidis, Marcos Jesus Araúzo-Bravo, Robert Thomas Brodell, Mohamed Hassan, Marcelo Luiz Bendhack · 2024 · International Journal of Molecular Sciences
  17. Mutant ATRX: pathogenesis of ATRX syndrome and cancer
    Kejia Yuan, Yan Hua Tang, Zexian Ding, Lei Peng, Jinghua Zeng, Huaying Wu, Qi Yi · 2024 · Frontiers in Molecular Biosciences
  18. Telomere regulation: lessons learnt from mice and men, potential opportunities in horses
    Joshua Denham · 2019 · Animal Genetics
  19. Using Transcriptional Signatures to Find Cancer Drivers with LURE
    David Haan, Ruikang Tao, Verena Friedl, Ioannis N. Anastopoulos, Christopher K. Wong, Alana S. Weinstein, Joshua M. Stuart · 2019 · Pacific Symposium on Biocomputing (PSB)
  20. The (epi)genomic landscape of splenic marginal zone lymphoma, biological implications, clinical utility, and future questions
    Carolina Jaramillo Oquendo, Helen Parker, David Graham Oscier, Sarah Ennis, Jane Gibson, Jonathan C. Strefford · 2021 · Journal of Translational Genetics and Genomics
  21. Template activating factor-I epigenetically regulates the TERT transcription in human cancer cells
    Kohsuke Kato, Atsushi Kawaguchi, Kyosuke Nagata · 2021 · Scientific Reports
  22. The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas
    Jie Xu, Fangping Xu, Zhihua Liu, Qian Cui, Ke-Ping Zhang, Zhi Li · 2022 · Medicine
  23. Telomere length sensitive regulation of interleukin receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment
    Ananda Kishore Mukherjee, Subhajit Dutta, Ankita Singh, Shalu Sharma, Shuvra Shekhar Roy, Antara Sengupta, Megha Chatterjee, Soujanya Vinayagamurthy, Sulochana Bagri, Divya Khanna et al. · 2024 · eLife
  24. Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma
    Chenxi Sun, Xu Liu, Tiantian Liu, Chenliu Fan, Yang Zi Jiang, Binggen Li, Huiyang Yuan, Chengyun Zheng, Dawei Xu · 2025 · Frontiers in Cell and Developmental Biology
  25. CDKN2A homozygous deletions and TSC2 somatic mutations in metastatic pancreatic neuroendocrine tumors
    Tito T. Jesus, Lorenzo Ferrando, Lia Rodrigues, Rui Sousa Martins, Luís Cardoso, José Manuel Lopes, Paula Soares, Arnaud Da Cruz Paula, João Vinagre · 2025 · npj Precision Oncology
  26. Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (TERT) gene expression status
    Aleksey Yu. Drobyshev, Alexander Modestov, Maria Suntsova, Elena V Poddubskaya, Alexander P. Seryakov, Aleksey Moisseev, Maxim Sorokin, Victor Tkachev, Г. С. Захарова, Aleksander Simonov et al. · 2024 · Frontiers in Genetics
  27. Design, Synthesis, Theoretical, Molecular Networking, In Silico and In Vitro Evaluation of Dehydrozingerone‐Based Mannich Derivatives as Promising Anticancer Agents
    Senthil Kumar Raju, Praveen Sekar, Badriyah Shadid Alotaibi, Murugesan Sankarganesh, Ajmal Rashid Bhat, Aso Hameed Hasan, Sumeer Ahmed, Mohammad Amjad Kamal · 2025 · ChemistrySelect
  28. Methylation of Subtelomeric Chromatin Modifies the Expression of the lncRNA TERRA, Disturbing Telomere Homeostasis
    Diego Oliva-Rico, Eunice Fabián-Morales, Rodrigo E. Cáceres-Gutiérrez, Adriana Gudiño, Fernanda Cisneros-Soberanis, Julieta Domínguez, Oscar Almaraz-Rojas, Cristian Arriaga-Canon, Clementina Castro Hernández, Carlos De la Rosa et al. · 2022 · International Journal of Molecular Sciences
  29. Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma
    Satarupa Sengupta, Shiva Senthil Kumar, Kathryn M. Bondra, Matthew Sobo, Xiaokui Molly Mo, Rachid Drissi · 2023 · Frontiers in Oncology
  30. TERT-independent telomere elongation and shelterin dysregulation after pulmonary exposure to stainless-steel welding fume in-vivo
    Mohammad Shoeb, Terence G. Meighan, Vamsi Kodali, Henry G. Abadin, OBAID M. FAROON, Gregory M. Zarus, Aaron Erdely, James Michael Antonini · 2024 · Environmental Research
  31. The RNA-binding protein CMSS1 promotes the progression of non-small cell lung cancer by regulating the telomerase protein subunit hTERT
    Wei Liang Gu, Hongshui Li, Lei Sun, Ziyi Shen, Yuanhui Wang, Xiaomeng Hu, Yan Wu, Wei Liu, Chunpeng Craig Wan, Yi Cai et al. · 2024 · Life Sciences
  32. Telomemore enables single-cell analysis of cell cycle and chromatin condensation
    Iryna Yakovenko, Ionut Sebastian Mihai, Martin Selinger, William Rosenbaum, Andy Dernstedt, Remigius Gröning, Johan Trygg, Laura M. Carroll, Mattias N.E. Forsell, Johan Henriksson · 2025 · Nucleic Acids Research
  33. Managing telomerase and telomere dysfunction in acral melanoma
    Vishnu Sravan Bollu, Yu‐Chi Chen, Fan Zhang, Krishne Gowda, Shantu Amin, Arun Kumar Sharma, Todd D. Schell, Jiyue Zhu, Gavin P. Robertson · 2025 · Pharmacological Research
  34. Alternative lengthening of telomeres confers favorable prognosis in chondrosarcomas
    Ji‐Yong Sung, Jin‐Hong Kim, Yi‐Jun Kim · 2025 · Journal of Translational Medicine
  35. Cancer Risks Linked to the Bad Luck Hypothesis and Epigenomic Mutational Signatures
    José Ernesto Belizário · 2018 · Epigenomes
  36. Three months-longitudinal changes in relative telomere length, blood chemistries, and self-report questionnaires in meditation practitioners compared to novice individuals during midlife
    Min-Kyu Sung, Eugene Koh, Yunjeong Kang, Jinhee Lee, Jiyeon Park, Ji Young Kim, Soyoung Shin, Yeon Hee Kim, Noriko Setou, Ul Soon Lee et al. · 2022 · Medicine
  37. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
    Tsung‐Jang Yeh, Chi‐Wen Luo, Jeng‐Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Benjamin Tzer-Ming Chuang, Yuh‐Ching Gau, Shih‐Feng Cho, Yi‐Chang Liu, Hui‐Hua Hsiao et al. · 2023 · Biomedicines
  38. An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma
    Yaning Cai, Hao Guo, JinPeng Zhou, Gang Zhu, Hongwen Qu, Lingyu Liu, Tao Shi, Shunnan Ge, Yan Qu · 2023 · Journal of Cancer Research and Clinical Oncology
  39. Reliable assessment of telomere maintenance mechanisms in neuroblastoma
    Alina Meeser, Christoph Bartenhagen, Lisa Werr, Anna‐Maria Hellmann, Yvonne Kahlert, Nadine Hemstedt, Peter Nürnberg, Janine Altmüller, Sandra Ackermann, Barbara Hero et al. · 2022 · Research Square
  40. Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation
    Tigran A. Harutyunyan, Anzhela Sargsyan, Lily Kalashyan, Hovhannes A. Igityan, Bagrat A. Grigoryan, Hakob Davtyan, Rouben M. Aroutiounian, Thomas Liehr, Galina G Hovhannisyan · 2024 · International Journal of Molecular Sciences
  41. Telomerase in cancer- ongoing quest and future discoveries
    Apurwa Mishra, Trupti Patel · 2025 · Molecular Biology Reports
  42. TERT promoter methylation predicts overall survival, immune cell infiltration and response to immunotherapy in clear cell renal cell carcinoma
    Xinyu Guan, Jiahao Meng, Wenjun Yi, Kun Ye, Hongyu Gao, Yue Hong, Limeng Qu, Shirong Ding, Long Qian · 2025 · Clinical Epigenetics
  43. Structural organization and function of telomeric chromatin
    Ruben van der Lugt, Jacqueline J.L. Jacobs · 2026 · Nature Cell Biology
  44. ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival
    Kathryn Demanelis, Julia Leix, Melissa Amber Burgess, Benjamin Alexander Nacev · 2026 · ESMO rare cancers.
  45. A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma
    Chen Ji, Dong Zhang, Xiangbin Ren, Peng Wang · 2023 · Aging
  46. Current Technologies for Measuring or Predicting Telomere Length from Genomic Datasets
    Ting Zhai, Zachary David Nagel · 2024 · Genetics.
  47. Pathogenic effects of telomerase reverse transcriptase (TERT) promoter mutations in nonalcoholic steatohepatitis (NASH) related hepatocellular carcinoma (HCC) and its potentials as a diagnostic biomarker
    Usman Umar Liman, Asanka Sudeshini Hawage, Sumadee De Silva, Saumya Madushani Samarasinghe, Kamani Hemamala Tennekoon, Rohan Chaminda Siriwardana, Madunil Anuk Niriella · 2025 · Egyptian Journal of Medical Human Genetics
  48. Integrated Bioinformatics and Experimental Approaches Identified the Role of NPPA in the Proliferation and the Malignant Behavior of Breast Cancer
    Aijun Sun, Xiaonan Sheng, Jinhai Tang, Zhenfeng Yu, Jian Zhang · 2021 · Journal of Immunology Research
  49. Anticancer activity, hTERT expression and telomere length analysis in SH-SY5Y neuroblastoma cell lines applied to docetaxel
    Nihal İnandıklıoğlu, Ayça Taş, Tugba Ağbektas, Zuhal Tunçbilek, Kayode Yomi Raheem, Gulcihan Cinar, Yavuz Siliğ · 2022 · Journal of Molecular Structure
  50. Pan-cancer pseudogene RNA analysis reveals a regulatory network promoting cancer cell proliferation
    Mengbiao Guo, Jingkai Zhang, Qiaoling Liang, Jianxi Zhu, Qi Wang, Zhengwen Fang, Zhou Songyang, Yuanyan Xiong · 2023 · Genome Instability & Disease
  51. An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review)
    Eleftheria Karaviti, Athanasios Kontogiannis, Aristotelis Anastopoulos, Elias Alexandros Kotteas, Georgia Gomatou · 2023 · Molecular and Clinical Oncology
  52. Transition Mutations in the hTERT Promoter Are Unrelated to Potential i-motif Formation in the C-Rich Strand
    James W. Conrad, Mark L. Sowers, Dianne Y. Yap, Ellie Cherryhomes, Bernard Montgomery Pettitt, Kamil Khanipov, Lawrence C. Sowers · 2023 · Biomolecules
  53. Assessment of MYC and TERT copy number variations in lung cancer using digital PCR
    Alexander Brik, Katharina Wichert, Daniel Gilbert Weber, Katja Szafranski, P. Rozynek, Swetlana Meier, Yon‐Dschun Ko, Reinhard Büttner, Klaus Bernhard Gerwert, Thomas Behrens et al. · 2023 · BMC Research Notes
  54. Olovnikov, Telomeres, and Telomerase. Is It Possible to Prolong a Healthy Life?
    Yegor E. Yegorov · 2023 · Biochemistry (Moscow)
  55. Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain
    Pashna N. Munshi, Shannon R. McCurdy · 2024 · American Journal of Hematology
  56. Cross-talk of Three Molecular Subtypes of Telomere Maintenance Defines Clinical Characteristics and Tumor Microenvironment in Gastric Cancer
    Mengpei Yan, Zhijun Zhang, Luyao Wang, Hongxin Huang, Jihuan Wang, Chengjun Zhu, Zheng Li, Zekuan Xu · 2024 · Journal of Cancer
  57. Discovery of telomerase inhibitors: existing strategies and emerging innovations
    Lauren Kageler, Elisa Aquilanti · 2024 · Biochemical Society Transactions
  58. The absence of telomerase leads to immune response and tumor regression in zebrafish melanoma
    Bruno Lopes-Bastos, Joana Nabais, Tânia Ferreira, Giulia Allavena, Mounir El Maï, Malia Bird, Seniye Targen, Lorenzo Tattini, Da Kang, Jia‐Xing Yue et al. · 2024 · Cell Reports
  59. Long telomeres cooperate with p53, MDM 2, and p21 polymorphisms to raise pediatric solid tumor risk
    Debasish Borbora, Hemonta Kumar Dutta, Kangjam Rekha Devi, Jagadish Mahanta, Pronita Medhi, Kanwar Narain · 2019 · Pediatrics International
  60. Epigenetic Characteristics of Human Subtelomeres Vary in Cells Utilizing the Alternative Lengthening of Telomeres (ALT) Pathway
    Shir Toubiana, Aya Tzur-Gilat, Sara Selig · 2021 · Life
  61. Short‐DNA Specific Blocker PCR for Efficient and Simple Enrichment of Cell Free Fetal DNAs with Short Lengths
    Yangwei Liao, Xiaofeng Tang, Zhihao Ming, Lida Ren, Wei Zhang, Xianjin Xiao · 2021 · Chinese Journal of Chemistry
  62. Mechanisms of telomere maintenance in pediatric brain tumors: Promising targets for therapy – A narrative review
    Felice Giangaspero, Simone Minasi, Francesca Gianno, Hiba Alzoubi, Manila Antonelli, Francesca Romana Buttarelli · 2020 · Glioma
  63. Liquid biopsy in neuro-oncology: are we finally there?
    Maxime Fontanilles, Marc Sanson, Mehdi Touat · 2021 · Annals of Oncology
  64. Therapeutic vulnerability to ATR inhibition in concurrent NF1 and ATRX-deficient high-grade solid tumors
    Ming Yuan, C. Eberhart, C. Pratilas, J. Blakeley, Christine Davis, Marija Stojanova, Karlyne M. Reilly, A. Meeker, C. Heaphy, F. Rodriguez · 2022 · bioRxiv
  65. AURKB and PI3K/AKT/mTOR pathways converge to regulate TERT expression
    Grace Lim, Althea Bastian, Saskia Fung, Farhana Mollah, Minh H. Nguyen, Adwoa A Sey, Marthe Cheade, Rozelle M. Harvie, Nisha R. Singh, Sergey Kurdyukov et al. · 2025 · iScience
  66. Combined Inhibition of telomerase and mitochondria synergistically promote apoptosis in AML cell lines
    Hossein Kalarestaghi, Khadijeh Dizaji Asl, Zeinab Mazloumi, Mohsen Hemmati-Dinarvand, Abbas Ghotaslou, Majid Nejati, Ali Rafat · 2025 · Medical Oncology
  67. INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell model
    Patrick DeSouza, Matthew Ishahak, Xuan Qu, Colin R. McCornack, Devi Annamalai, Diane D. Mao, Rajanikanth Vangipurapu, Yiwei Fu, Alexandre Teixeira Vessoni, Ryan T. Cleary et al. · 2025 · Nature Communications
  68. Expanding the Morphologic and Molecular Spectrum of Spindle Cell Tumors Associated With TERT Fusions
    Susan Swee‐Shan Hue, Carla Saoud, Dorukhan H. Bahceci, Liliana B. Villafania, Jamal K. Benhamida, Cristina R. Antonescu · 2025 · Genes Chromosomes and Cancer
  69. Hematological complications in solid organ transplant recipients with telomere biology disorders: a narrative review
    François Michel Carlier, Thomas Planté-Bordeneuve, Antoine Froidure, Carlos Graux, Marie‐Astrid van Dievoet, Coline H.M. van Moorsel, Thijs W. Hoffman · 2026 · Frontiers in Immunology
  70. 7-T MRI intratumoral susceptibility signals reflect biomarker status in gliomas
    Fengwei Yu, Ke Li, Zilong Li, Suyi Zhou, Wei Chen, Chaodong Xiang, Jiafei Chen, Zhentao Zuo, Zhiming Zhen, Wei Chen · 2026 · European Radiology Experimental
  71. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors
    Ju‐Yoon Yoon, Wei Hong Jiang, Christopher R. Orr, Chase Rushton, Stacey Gargano, Sharon J. Song, Mitul Modi, Bryan A. Hozack, John A. Abraham, Atrayee Basu Mallick et al. · 2021 · Cancer Genetics
  72. Importancia pronóstica de las mutaciones del gen promotor de la transcriptasa inversa de la telomerasa en los meningiomas de alto grado
    Alejandro Ramírez Cañas, Enrique Jiménez, Fernando Hakim, Juan Armando Mejía, Juan Fernando Ramón, Diego Gómez, Daniel Jaramillo-Velásquez, Sonia Bermúdez, Nicolás Useche, Diego Pineda et al. · 2022 · Biomédica
  73. Current Progress in Targeting Telomere and Telomerase Enzymes for the Treatment of Cancer
    Aakriti Garg, Imran Khan, Nidhi Nidhi, Mohd Ashif Khan · 2023 · Current Cancer Therapy Reviews
  74. Differential whole-genome doubling based signatures for improvement on clinical outcomes and drug response in patients with breast cancer
    Yingli Lv, Guotao Feng, Lei Yang, Xiaoliang Wu, Chengyi Wang, Aokun Ye, Shuyuan Wang, Chaohan Xu, Hongbo Shi · 2024 · Heliyon
  75. Multiple factors influence telomere length and DNA damage in individuals environmentally exposed to a coal-burning power plant
    Melissa Rosa de Souza, Ana Letícia Hilário Garcia, Daiana Dalberto, Juliana Picinini, Luciana Bavaresco Andrade Touguinha, Mirian Mendonça Salvador, Juliana da Silva · 2024 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  76. Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma
    Jerry P. Vriend, Xiaoqing Liu · 2024 · International Journal of Molecular Sciences
  77. Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression
    Philip Kienzl, Abigail Joyce Deloria, Monika Hunjadi, Juliane M. Hadolt, Max-Felix Haering, Angrit Bothien, Doris Mejri, Medina Korkut-Demirbaş, Sandra Sampl, Gerhard Weber et al. · 2024 · Cellular Oncology
  78. Exercise to combat cancer: focusing on the ends
    Joshua Denham, Edward Bliss, Tracy M. Bryan, Brendan J. O’Brien, Dean E. Mills · 2024 · Physiological Genomics
  79. Human Chromosome Telomeres
    Florencia María Barbé‐Tuana, Lucas Kich Grün, Vinícius Pierdoná, Beatriz C. D. de Oliveira, Stephany Cacete de Paiva, Mark Ewusi Shiburah, Vítor Luiz da Silva, Edna Gicela Ortiz Morea, Veronica Silva Fontes, Maria Isabel Nogueira Cano · 2021 · Springer eBooks
  80. ChArmTelo Enables Large‐Scale Chromosome Arm‐Level Telomere Analysis across Human Populations and in Cancer Patients
    Mengbiao Guo, Zhou Songyang, Yuanyan Xiong · 2023 · Small Methods
  81. Precision Medicine in Brain Tumors: New Approaches
    Meisam Akhlaghdoust, Sanaz Bordbar, Mohammad Nikoohemmat, Elahe Meftah, Milad Rahimzadegan, Setareh Akbari, Alireza Zali · 2024 · Interdisciplinary cancer research
  82. Télomères et télomérase : des cibles toujours pertinentes en oncologie ?
    Jean‐Louis Mergny, Lionel Guittat, Évelyne Ségal-Bendirdjian · 2020 · Bulletin du Cancer
  83. Portrayal of the human blood transcriptome of 3,388 adults and its relation to ageing and health
    Maria Schmidt, Henry Loeffler‐Wirth, Lydia Hopp, Arsen Arakelyan, Holger Kirsten, Knut Krohn, Ralph Burkhardt, Kerstin Wirkner, Joachim Thiery, Christoph Engel et al. · 2019
  84. Undifferentiated Sarcomas Develop Through Distinct Evolutionary Pathways
    Christopher D. Steele, Maxime Tarabichi, Ludmil B. Alexandrov, Dahmane Oukrif, Hongtao Ye, Matthew W. Fittall, Patrick Lombard, Iñigo Martincorena, Patrick S. Tarpey, Grace Collord et al. · 2018 · SSRN Electronic Journal
  85. Loose ends in cancer genome structure
    Julie M. Behr, Xiaotong Yao, Kevin Hadi, Huasong Tian, Aditya S. Deshpande, Joel A. Rosiene, Titia de Lange, Marcin B. Imielinski · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations
    Raúl Sánchez-Vazquez, Sonia Burgaz García-Oteyza, Rosa Serrano, Juana María Flores, Paula Martínez, Marı́a A. Blasco · 2025 · Genes & Development
  87. Association and causal impact of TERT genetic variants on peripheral blood leukocyte telomere length and cerebral small vessel disease risk in a Chinese Han population: a mendelian randomization analysis
    Ying Song, Jia-Liang Xu, Wanru Geng, Long Yin, Jialu Wang, Jiu-Han Zhao · 2024 · Orphanet Journal of Rare Diseases
  88. Beginning at the ends: telomere and telomere-based cancer therapeutics
    Zahra Sadr, Masoumeh Ghasemi, Soheyla Jafarpour, Reyhaneh Seyfi, Aida Ghasemi, Elham Boustanipour, Hamid Reza Khorram Khorshid, Naeim Ehtesham · 2024 · Molecular Genetics and Genomics
  89. Rapid loss of viability in acute myeloid leukemia cells upon telomerase inactivation
    Elisa Aquilanti, Lauren Kageler, Vincent Bozinov, Matthew M. Meyerson · 2025 · Blood Advances
  90. Stratification of telomerase activity in cancer reveals associations with senescence and genomic instability
    Nighat Noureen, Min H. Kang · 2025 · Computational and Structural Biotechnology Journal
  91. Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas
    Bo Deng, Rania Head, Kaspar Draaisma, Ann Hoeben, Slávka Lukacova, Giuseppe Lombardi, Sieger Leenstra, Monique C.J. Hanse, Ruth E. M. Fleischeuer, Colin Watts et al. · 2025 · Neuro-Oncology
  92. Value of TERT promoter mutations for early outcomes in papillary thyroid cancer
    Min Jhi Kim, Daham Kim, Hye Sun Lee, Se Hee Park, Eun Jin Kim, Jin Kyong Kim, S M Kang, Jandee Lee, Jong Ju Jeong, Woong Youn Chung et al. · 2026 · Endocrine Related Cancer
  93. Beyond chromatin accessibility: bulk ATAC-seq as an integrative assay to portray genomes and epigenomes
    Islem Toumi, Chaimae Kham, Lucille Stuani, Laurent Le Cam, Pierre‐François Roux · 2026 · NAR Genomics and Bioinformatics
  94. How telomere attrition protects against cancer
    Alexander Stuart, Bokai Zhang, Dirk F. Hockemeyer, Titia de Lange · 2026 · Nature Reviews Genetics
  95. A Novel Liquid Biopsy Strategy to Detect Small Amounts of Cancer Cells Using Cancer-Specific Replication Adenoviruses
    Masahiro Takakura, Emi Takata, Toshiyuki Sasagawa · 2020 · Journal of Clinical Medicine
  96. Clinical, Morphological, and Molecular Study of Diffuse WHO Grade II and III Astrocytomas: A Retrospective Analysis from a Single Tertiary Care Institute
    Ramya Lakshmi Veduruvada, Megha S. Uppin, Meher Lakshmi Konatam, Rajesh Alugolu, Vamsi Krishna Yerramneni, Suchanda Bhattacharjee, Mudumba Vijaya Saradhi, Monica Malik Irukulla, M. Nageshwar Rao, Nagaraj Velugonda · 2021 · Indian Journal of Medical and Paediatric Oncology
  97. Evaluation of hTERT Gene Expression and Chromosome 7 Copy Number Variation in Anal Squamous Intra-Epithelial Lesions
    Tanvi Arora, Neelam Wadhwa, Divya Aggarwal, Deepika Pandhi, Preeti Diwaker, Vinod K. Arora · 2022 · Journal of Cytology
  98. Pediatric Melanoma
    Armita Bahrami · 2018 · Elsevier eBooks
  99. New approaches to vaccines for cancer
    Vivek P. Chavda, Devarshi Acharya, Saloni Malla, Charles R. Ashby, Amit Kumar Tiwari · 2024 · Elsevier eBooks
  100. Investigating the Shared Genetic Architecture Between Leukocyte Telomere Length and Prostate Cancer
    Zhizhou Li, Maoyu Wang, Shuxiong Zeng, Ziwei Wang, Yidie Ying, Qing Chen, Chen Zhang, Wei He, Chaoyang Sheng, Yi Wang et al. · 2024 · The World Journal of Men s Health